00648nas a2200205   4500000000100000008004100001100001500042700001500057700001700072700001700089700001200106700001500118700001400133700001500147700001700162245021800179300000700397490000600404022003200410       2020                            d1 aP. Bidulka1 aM. Iwagami1 aK. Mansfield1 aF. Kalogirou1 aA. Wong1 aI. Douglas1 aL. Smeeth1 aC. Summers1 aL. Tomlinson00aComparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study  a770 v5  a2398-502X (Print) 2398-502x